Nature Cancer, Published online: 16 January 2026; doi:10.1038/s43018-025-01110-1Yabut and Drucker discuss clinical and preclinical evidence about the potential roles of GLP-1 medicines on cancer incidence, development and therapy and speculate about their mechanism on cancer cells and the tumor microenvironment.